Kenya’s Maisha Meds Awarded $5 Million by USAID to Help It Scale
By Tom Jackson
Kenya’s Maisha Meds, a leading digital health organisation in Africa, has received US$5.25 million in scale-up stage 3 funding from the United States Agency for International Development (USAID) Development Innovation Ventures (DIV).
Maisha Meds is a software platform for ensuring that rural pharmacists and clinicians effectively purchase quality affordable medicines and pass on subsidies to patients
Photo courtesy of Pete Lewis / DFID.